Abstract
Glutaric acidemia type II and carnitine palmitoyltransferase type II deficiency are rare, but potentially treatable, inherited metabolic diseases. Hallmarks of the early onset form of both conditions are renal abnormalities and neonatal metabolic crisis. In this article, we report on two newborns with cystic renal dysplasia as a leading sign of these metabolic diseases. We focus on the clinical presentation and discuss the diagnostic tests and the available therapeutic options. We conclude that prenatal diagnosis of cystic renal dysplasia should alert the physician to the possibility of these metabolic diseases. This knowledge should prompt careful observation and, where necessary, early intervention during the postnatal period of catabolism.
This is a preview of subscription content, log in via an institution to check access.
References
Frerman FE, Goodman SI (2001) Defects of electron transfer flavo-protein and electron transfer flavoprotein-ubiquinone oxidoreductase:glutaric acidemia type II. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 2357–2365
Bonnefont JP, Demaugre F, Prip-Buus C, Saudubray JM, Brivet M, Abadi N, Thuillier L (1999) Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 68:424–440
McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49:395–420
Hug G, Soukup S, Berry H, Bove K (1989) Carnitine palmityl transferase (CPT): deficiency of CPT II but not of CPT I with reduced total and free carnitine but increased acylcarnitine. Pediatr Res 25:115A
North KN, Hoppel CL, De Girolami U, Kozakewich HP, Korson MS (1995) Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 127:414–420
Elpeleg ON, Hammerman C, Saada A, Shaag A, Golzand E, Hochner-Celnikier D, Berger I, Nadjari M (2001) Antenatal presentation of carnitine palmitoyltransferase II deficiency. Am J Med Genet 102:183–187
Przyrembel H, Wendel U, Becker K, Bremer HJ, Bruinvis L, Ketting D, Wadman SK (1976) Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta 66:227–239
Lehnert W, Wendel U, Lindenmaier S, Bohm N (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings. Eur J Pediatr 139:56–59
Wilson GN, de Chadarevian JP, Kaplan P, Loehr JP, Frerman FE, Goodman SI (1989) Glutaric aciduria type II: review of the phenotype and report of an unusual glomerulopathy. Am J Med Genet 32:395–401
Curcoy A, Olsen RK, Ribes A, Trenchs V, Vilaseca MA, Campistol J, Osorio JH, Andresen BS, Gregersen N (2003) Late-onset form of beta-electron transfer flavoprotein deficiency. Mol Genet Metab 78:247–249
Bohm N, Uy J, Kiessling M, Lehnert W (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 139:60–65
Harkin JC, Gill WL, Shapira E (1986) Glutaric acidemia type II. phenotypic findings and ultrastructural studies of brain and kidney. Arch Path Lab Med 110:399–401
Colevas AD, Edwards JL, Hruban RH, Mitchell GA, Valle D, Hutchins GM (1988) Glutaric acidemia type II: comparison of pathologic features in two infants. Arch Path Lab Med 112:1133–1139
Friedmann W, Vogel M, Dimer JS, Luttkus A, Buscher U, Dudenhausen JW (2000) Perinatal differential diagnosis of cystic kidney disease and urinary tract obstruction: anatomic pathologic, ultrasonographic and genetic findings. Eur J Obstet Gynecol Reprod Biol 89:127–133
Guay-Woodford LM (2006) Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex. Pediatr Nephrol 21:1369–1376
Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A (2006) Renal cystic disease—a review. Adv Anat Pathol 13:26–56
Mooy PD, Przyrembel H, Giesberts MA, Scholte HR, Blom W, van Gelderen HH (1984) Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin. Eur J Pediatr 143:92–95
Ogier de Baulny H (2002) Management and emergency treatment of neonates with a suspicion of inborn errors of metabolism. Semin Neonatol 7:17–26
Stanley CA (2000) Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, Van den Berghe G (eds) (2000) Inborn metabolic diseases. Diagnosis and treatment, 3rd edn. Springer, Berlin, pp 140–150
Acknowledgements
We would like to thank Varun Kumar Prabhakar, University of Hertfordshire, UK, for critically proofreading this manuscript.
Disclosure: The authors report no conflicts of interest and no financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Distelmaier, F., Vogel, M., Spiekerkötter, U. et al. Cystic renal dysplasia as a leading sign of inherited metabolic disease. Pediatr Nephrol 22, 2119–2124 (2007). https://doi.org/10.1007/s00467-007-0536-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0536-9